Skip to content
HOMETECH DIRECTORYNEWS & DEVELOPMENTSRELOCATEEMPLOYERSNEIGHBORHOODSABOUTSchedule a Call

Ann Arbor Biotech Companies (2026)

The 2026 hub for Ann Arbor biotech: Esperion (NASDAQ: ESPR), HistoSonics, Strata Oncology, Akadeum, Workit, Genomenon, ArborMetrix, Sartorius, and the r...

A2Hub Editorial· Rusty Roof Media· Updated May 4, 2026

Ann Arbor Biotech Companies (2026)

By A2Hub Editorial. Published 2026-04-22. Last updated 2026-04-22.

The verdict

Ann Arbor is a serious life sciences city with a small but commercially proven therapeutics bench, a deep medtech and diagnostics lineage, a working SaaS-meets-clinical-research stack, and a real bioanalytics infrastructure layer (Sartorius, MI-HQ wet labs) that did not exist five years ago. Esperion Therapeutics anchors the publicly traded therapeutics side from NASDAQ. HistoSonics anchors the medtech unicorn story. Genomenon and Strata Oncology anchor the AI-meets-genomic-medicine side. Workit Health anchors the digital health side. Behind them is a 100-plus-person nonprofit research organization (Arbor Research Collaborative for Health), a 1,000-plus-employee global medical-device employer (Terumo Cardiovascular), and a $100 million Sartorius Center of Excellence on Research Park Drive that turns the cluster into a real biomanufacturing node.

The pedigree comes from three exits that put hundreds of millions of dollars into local operators: HandyLab to BD for $275 million in 2009 (closed November 2009, roughly 60 employees in Pittsfield Township), Accuri Cytometers to BD for $205 million in March 2011 (Scio Township-based), and NeuMoDx to QIAGEN in September 2020 with Arboretum Ventures as a backer. The HandyLab and Accuri founders, executives, and engineers are the people who today populate HistoSonics, Akadeum, Strata Oncology, Ripple Science, and a bench of others. When people ask why Ann Arbor punches above its weight in life sciences, the HandyLab plus Accuri plus NeuMoDx lineage is the honest answer.

Before the list, a definition. When people search "Ann Arbor biotech companies" they usually mean three different industries mashed together. Biotech in the strict sense means therapeutics: drugs, gene therapies, cell therapies, RNA platforms. In Ann Arbor that is Esperion, ONL Therapeutics, Strata Oncology, TSRL, CircNova, and Ambient Biosciences. Medtech means devices and diagnostics: HistoSonics, Akadeum, Terumo Cardiovascular, and the broader medical-device list (covered in detail on the Ann Arbor medtech companies hub). Digital health and clinical-research SaaS is software for clinicians, patients, payers, and researchers: Workit Health, Genomenon, Ripple Science, TRAILS, ArborMetrix, and Arbor Research Collaborative. We split them up on purpose; the cap tables, FDA pathways, hiring patterns, and capital sources look nothing alike across the three.

The talent engine behind all of it is the University of Michigan. The Life Sciences Institute, Michigan Medicine, Innovation Partnerships (ranked #2 nationally for startup launches in the 2023 AUTM survey, with 502 invention disclosures and 169 U.S. patents in fiscal 2021), the Coulter Translational Research Partnership, and MTRAC Life Sciences supply a steady pipeline of spinouts. Arboretum Ventures, headquartered in Ann Arbor since 2002 with $1 billion-plus raised across six funds (Fund VI closed 2023 at $268 million), provides the regional capital. MI-HQ supplies the wet-lab space. Sartorius supplies the bioanalytical service. The pieces are in place.

The Companies

  • Esperion Therapeutics (NASDAQ: ESPR) is Ann Arbor's only commercial-stage listed biopharma. HQ Ann Arbor. Develops cardiometabolic therapies for patients whose LDL-C is not controlled by statins alone. Lead molecule bempedoic acid sells as NEXLETOL and, in combination with ezetimibe, as NEXLIZET. In September 2025 the company added Enbumyst to its portfolio following the Corstasis Therapeutics acquisition. Market capitalization sat near $732 million in March 2026. The reference implementation for what commercial biopharma looks like inside a college town.

  • ArborMetrix builds healthcare real-world data analytics. Founded in 2011 as a U-M and Dartmouth spinout. HQ downtown Ann Arbor on Liberty Street. Approximately $33 million raised. Customers include medical specialty societies, providers, payers, and government. Recently launched AMxEngage for patient-reported outcomes. The clearest Ann Arbor example of clinical-data SaaS that scaled to a sustainable mid-stage business without an exit yet.

  • ONL Therapeutics is clinical-stage ocular neuroprotection. U-M spinout, HQ Ann Arbor. Developing small-molecule therapies intended to halt photoreceptor cell death in retinal diseases. The deeply technical, patient pre-commercial biopharma that Ann Arbor produces regularly but rarely publicizes. Ophthalmology is a big, underserved market, and ONL is one of the few Michigan plays into it.

  • Strata Oncology runs the Strata Trial precision oncology network. Founded in 2015 by Dan Rhodes and Scott Tomlins (both U-M) with Keith Flaherty of Mass General. HQ Ann Arbor. Raised what press releases described as a $90 million round in July 2021. Ships StrataNGS tumor sequencing and Strata Select for matched-trial enrollment across community health systems and pharma partners. The rare AA biotech operating between data, diagnostics, and drug development.

  • Akadeum Life Sciences commercialized buoyancy-activated cell sorting (BACS), a microbubble-based technology for separating cells without magnets or centrifuges. Founded in 2014 in Ann Arbor. The Alerion cell separation system launched in 2023. Closed a financing round of more than $20 million in June 2025. Textbook Ann Arbor medtech: U-M-adjacent research, local capital, product shipping to labs worldwide.

  • Workit Health is telehealth addiction treatment. Founded in 2015 by Robin McIntosh and Lisa McLaughlin, both in recovery themselves. HQ 3300 Washtenaw Avenue, Ann Arbor. Closed a $118 million Series C in October 2021 led by Insight Partners at a reported $500 million valuation, with CVS Health Ventures, FirstMark, BCBS Venture, and 3L Capital participating. Operates a virtual clinic providing buprenorphine and naltrexone treatment plus counseling. Among Ann Arbor digital health companies, the clearest mission-driven B2C scale story.

  • Genomenon runs the Mastermind Genomic Search Engine, indexing more than 40 million scientific articles for variant-level evidence. More than 1,000 genetic testing labs and hospitals use the platform. U-M spinout, HQ Ann Arbor. Approximately $36.8 million raised; $20 million Series B led by Beringea in 2022. Occupies one of the most defensible niches in applied AI for biotech: comprehensive, curated, up-to-date evidence for clinical variant calls.

  • Ripple Science builds clinical trial recruitment and patient engagement SaaS (formerly under the EnrollNow brand). Founded in 2016. HQ Ann Arbor. Customers include Johns Hopkins, UCLA, Penn State, University of Michigan, and Cognito Therapeutics. Differentiated by focusing on the recruitment and engagement problem rather than trying to own the full EDC stack.

  • Ambient Biosciences focuses on biomolecule stabilization technology. Founded 2017, Ann Arbor. A Series A of roughly $9.15 million was disclosed in public records. Current operational status should be verified before deeper coverage. Included for completeness because the technology is real and has applications spanning diagnostics through vaccines.

  • TSRL Inc. is one of Ann Arbor's longest-running therapeutics shops. Founded 1986. Develops therapies for infectious diseases, funded substantially through NIH grants rather than venture equity. Included because TSRL's longevity and NIH relationships say something real about the kind of patient, grant-funded biotech work Ann Arbor supports.

  • TRAILS (Transforming Research into Action to Improve the Lives of Students) provides evidence-based mental health programming, training, and implementation support for K-12 schools. Founded 2013 at U-M. Approximately 115 employees per Built In. HQ Ann Arbor. Part SaaS, part training services, part nonprofit. One of the more important digital-health-adjacent employers in Washtenaw County and a rare example of mental health infrastructure that actually reaches schools.

  • Arbor Research Collaborative for Health is a 100-plus-person nonprofit health services research organization. Decades of work on kidney disease (the DOPPS study), cardiovascular disease, and population health. Based in Ann Arbor. A major employer of biostatisticians, epidemiologists, and clinical data engineers in the region.

  • Sartorius Ann Arbor Center of Excellence is the $100 million, 130,000 square-foot bioanalytics flagship at 3874 Research Park Drive. Combines biology labs, manufacturing capacity, warehouse, training, and a Customer Interaction Center. Won Ann Arbor SPARK's 2023 Business Development Project of the Year. For Ann Arbor biotech, Sartorius means on-the-ground access to bioanalytical service, process development, and a serious contract partner without a flight to Boston or Raleigh.

  • CircNova is using AI to generate, analyze, and identify circular RNA (circRNA) for therapeutic development. Ann Arbor based. Specific funding totals unconfirmed at time of writing. Early stage; worth tracking because circRNA has been one of the most active research areas in RNA therapeutics.

The exits that built this cluster

Three exits set the foundation. HandyLab, a U-M molecular diagnostics spinout founded by Kalyan Handique and Sundu Brahmasandra, was acquired by BD in 2009 for approximately $275 million; the deal closed November 2009 and the MAX platform is still on the market. Accuri Cytometers, another U-M spinout (Collin Rich and Jennifer Baird), sold to BD in March 2011 for $205 million, based in Scio Township at the time. NeuMoDx, a follow-on diagnostics venture from the HandyLab team, was acquired by QIAGEN in September 2020 with Arboretum Ventures as a backer. Those three transactions put hundreds of millions of dollars into local hands and produced the founder, executive, and senior-engineer pipeline that today populates HistoSonics, Akadeum, Strata Oncology, Ripple Science, and the broader bench. Most life-sciences clusters in mid-size cities never get one exit at that scale; Ann Arbor strung three across eleven years.

Adjacent verticals

Ann Arbor biotech overlaps four other categories on this site. Ann Arbor medtech companies is the closest sibling: HistoSonics, Akadeum, Terumo Cardiovascular, BedConnect, Akervall, and the device-and-diagnostics half of the cluster live there in greater detail. Ann Arbor AI companies overlaps via Genomenon, CircNova, and the broader applied-ML-in-biology trend. Ann Arbor SaaS companies overlaps via ArborMetrix, Ripple Science, and the clinical-research software stack. Ann Arbor venture capital is the capital-stack hub anchored by Arboretum Ventures.

Related

FAQ

How many biotech companies are in Ann Arbor? Washtenaw County hosts more than 250 life sciences firms by SPARK's broadest count, including support services, contract research, and small specialty shops. The publishable, named, product-shipping commercial biotech and digital-health entities on this hub number 14 (Esperion, ArborMetrix, ONL, Strata Oncology, Akadeum, Workit, Genomenon, Ripple, Ambient, TSRL, TRAILS, Arbor Research, Sartorius, CircNova). Adding the medtech-specific companies covered on the medtech hub (HistoSonics, Terumo, BedConnect, M3D, Akervall) brings the publishable cluster to 19.

Who is the largest biotech employer in Ann Arbor? Terumo Cardiovascular Systems, with more than 1,000 employees at 6200 Jackson Road, is the largest single life-sciences-by-headcount employer in the region, though it is more precisely a medtech device company than a biotech in the therapeutics sense. Esperion Therapeutics is the largest commercial-stage biopharma. Arbor Research Collaborative for Health (100-plus employees) is the largest nonprofit research organization. TRAILS (115 employees) is the largest digital-health-adjacent employer.

What is the salary range for biotech roles in Ann Arbor? Per Glassdoor and Salary.com aggregates for 2024-2025, mid-level scientist roles in Ann Arbor cluster around $85,000 to $130,000 base, with senior scientists in the $130,000 to $180,000 base range. Engineering and software roles inside biotech and digital health (Genomenon, Ripple Science, ArborMetrix, Workit) pay closer to the AA software bands ($140,000 to $200,000 mid to senior). Esperion and HistoSonics commercial-stage roles (sales, MSL, regulatory) carry industry-standard biopharma premiums.

Where is the Ann Arbor biotech cluster geographically? Three nodes. Downtown for ArborMetrix, Workit, and several digital-health teams. Research Park Drive and the Ellsworth corridor for Sartorius, KLA-adjacent labs, and the larger industrial-scale biotech footprint. The Pittsfield Township and Scio Township edges for the historical HandyLab, Accuri, and NeuMoDx footprints (now mostly absorbed into BD and QIAGEN operations). MI-HQ in Ann Arbor and Ypsilanti (the redeveloped former EMU College of Business) hosts the seed-stage wet-lab pool.

What is the difference between biotech and medtech in Ann Arbor? Biotech in the strict sense means therapeutics, regulated through FDA NDA or BLA pathways, with multi-year clinical trials and PhD-heavy hiring (Esperion, ONL, Strata Oncology, TSRL). Medtech means devices and diagnostics, regulated through 510(k) or De Novo pathways, with engineering-heavy hiring and earlier revenue (HistoSonics, Terumo, Akadeum). The same pool of investors (Arboretum) and the same university feeder (U-M) backs both, but the operating realities are different. We split them across two hubs on purpose.